Maegim

Stock search

Search by company name, 6-digit code, or Korean initials (e.g. ㅅㅅㅈㅈ)

☆한국어

NEXTBIOMEDICAL Co., Ltd.

넥스트바이오메디컬389650KOSDAQSector: Electronics & Semiconductors
₩33,3500.45%Market cap ₩276.0BAs of Sep 1, 2026 close · updated once daily
Market cap
₩276.0B
#303 in KOSDAQ
Loss
PER not computable
5.74x
Sector median 1.19x
0.0%
Sector median 0.0%
B
Grade B54.4 ptsTop 45% of 2,523 graded stocksMethodology v2.0
Financial strength
60.1/100
Growth momentum
86.8/100
Price attractiveness
27.9/100
Shareholder Return
33.6/100

As of Sep 1, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

How to read this grade
SABCurrentCDF

Toward S means a higher total-score band; toward F, a lower band. Badges are distinguished by ink intensity and shape (fill, outline, dashed) — never by hue.

Maegim maps a total score — built from sector-relative percentile scoring — onto fixed, predefined thresholds to assign one of six bands, S to F. This stock is scored by the same formula as all 2,523 graded stocks and is currently in band B with a total score of 54.4 points.

How grades are computed →What grades do and don’t mean →What the grade does not reflect →

Position within sector

Mechanically selected indicators in the top or bottom 30% of sector percentiles · among 492 stocks in Electronics & Semiconductors

1-year closing price

Loading closing price history…
 
Low ₩32,300High ₩98,000
Latest close
Price change by period
1W
1.20%
1M
3.70%
3M
18.20%
1Y
47.50%

As of the Sep 1, 2026 close · updated once daily · a factual record computed from closing prices only; dividends are not included, and this is not a buy or sell signal.

1

Financial strength

60.1/100
How much debt does it carry relative to equity?
23.2%
Sector median 61.3%
Sector lowhighTop 19.9% in sector
Can it cover what's due within a year?
537.9%
Sector median 185.8%
Sector lowhighTop 14.7% in sector
How much of revenue becomes profit?
-4.4%
Sector median 2.0%
Sector lowhighBottom 32.9% in sector
How much did it earn on its own capital?
-0.6%
Sector median 2.1%
Sector lowhighBottom 42% in sector

Source filing: annual report (separate) — view original ↗

2

Growth momentum

86.8/100
How much did revenue grow in a year?
72.7%
Sector median 4.4%
Sector lowhighTop 5% in sector
Did core profits grow in a year?
79.9%
Sector median 2.2%
Sector lowhighTop 21.5% in sector

Financial trend

Revenue

Growth & margin

Revenue growth Operating margin

Year over year — alongside the sector median

This stock Sector median

A factual chart of confirmed annual results from annual reports — the same source as the grading indicators. Not a buy or sell signal.

Source filing: annual report (separate) — view original ↗

3

Price attractiveness

27.9/100
Is the price expensive relative to earnings?
Loss-making (P/E not computable)
Sector median P/E of profitable peers 17.5x · 43% loss-making
Sector lowhighBottom 43.1% in sector
Is the price expensive relative to book value?
5.74x
Sector median 1.19x
Sector lowhighBottom 12.7% in sector

Valuation uses the Sep 1, 2026 close and market cap

4

Shareholder Return

Single-indicator axis33.6/100
Does the company actually pay dividends?
0.0%
Sector median 0.0%
Sector lowhighBottom 33.6% in sector

Source filing: annual report (separate) — view original ↗

Financial checklist

Based on the FY2025 annual report · year-over-year comparison · determined on Sep 2, 2026

Of 9 items: 5 met · 1 not met · 3 not computable

Not metMetNot computable

Positive net income
Whether net income (attributable to owners where available) is above zero.
Not met
-₩311M
Positive operating cash flow
Whether cash flow from operations is above zero.
Met
₩1.3B
Return on assets up
Whether net income over beginning total assets rose from the prior year.
Not computable

Not computed — required financial data is unavailable

Operating cash flow exceeds net income
Whether operating cash flow is greater than net income.
Met
₩1.3B vs -₩311M
Liabilities-to-assets ratio down
Whether total liabilities as a share of total assets fell from the prior year.
Met
23.2% → 18.8%
Current ratio up
Whether current assets over current liabilities rose from the prior year.
Met
394.5% → 537.9%
Shares outstanding not increased
Whether common shares issued did not increase from the prior year. Increases from bonus issues and stock dividends are also counted.
Not computable

Not computed — share count data is unavailable

Operating margin up
Whether operating income over revenue rose from the prior year.
Met
-37.5% → -4.4%
Asset turnover up
Whether revenue over beginning total assets rose from the prior year.
Not computable

Not computed — required financial data is unavailable

A record of facts determined by fixed rules from the financial statements in the latest annual report. Not used in grading, and not a buy or sell signal. Source filing: annual report (separate) — view original ↗

Grade change history

Jul 23, 2026B

Methodology version change (v2.0 applied)

Jul 15, 2026BVersion v1

First calculation

Grade changes are a factual record produced from public data by a fixed formula; they do not signal future changes.

Recent filings for this stock

Last 120 days · monitored filing types only
Periodic report filedAug 10, 2026Source ↗
Periodic report filedMay 15, 2026Source ↗

View in the filings calendar →